Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of anatibant (XY2405) for acute traumatic brain injury
ISRCTN23625128Phase 2Terminated
- Sponsor
- Xytis
- Start
- Nov 2006
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in traumatic brain injury (TBI) comparing Anatibant dose-finding arm with Placebo arm (2 arms). Started Nov 2006; status: terminated.
02
Drugs
anatibant
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ISRCTN23625128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN23625128.